Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Shares Outstanding (Weighted Average): 2023-2024

Historic Shares Outstanding (Weighted Average) for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $53.6 million.

  • Upstream Bio's Shares Outstanding (Weighted Average) rose 0.58% to $53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.9 million, marking a year-over-year increase of 0.58%. This contributed to the annual value of $53.6 million for FY2024, which is 47.48% up from last year.
  • Latest data reveals that Upstream Bio reported Shares Outstanding (Weighted Average) of $53.6 million as of FY2024, which was up 47.48% from $36.3 million recorded in FY2023.
  • In the past 5 years, Upstream Bio's Shares Outstanding (Weighted Average) ranged from a high of $53.6 million in FY2024 and a low of $36.3 million during FY2023.
  • In the last 2 years, Upstream Bio's Shares Outstanding (Weighted Average) had a median value of $45.0 million in 2023 and averaged $45.0 million.
  • Data for Upstream Bio's Shares Outstanding (Weighted Average) shows a peak YoY soared of 47.48% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Upstream Bio's Shares Outstanding (Weighted Average) stood at $36.3 million in 2023, then skyrocketed by 47.48% to $53.6 million in 2024.